Design and synthesis of some new quinoline-3-carbohydrazone derivatives as potential antimycobacterial agents

Bioorganic and Medicinal Chemistry Letters

Volumn 20, Issue 3, 2010, Pages 1040-1044

  Eswaran, Sumesh ^a   Adhikari, Airody Vasudeva ^b   Pal, Nishith K ^c   Chowdhury, Imran H ^c  

^a Anthem Biosciences Pvt Ltd   (India)

^b NATIONAL INSTITUTE OF TECHNOLOGY KARNATAKA   (India)

^c CALCUTTA SCHOOL OF TROPICAL MEDICINE   (India)

Author keywords

(3R) 3 Amino N,N dimethyl 4 (phenylthio)butanamide; Antituberculosis activity; Quinoline 3 carbohydrazone; TMC 207

Indexed keywords

ANTIMYCOBACTERIAL AGENT; ISONIAZID; QUINOLINE 3 CARBOHYDRAZONE DERIVATIVE; QUINOLINE DERIVATIVE; RIFAMPICIN; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; HYDRAZONE DERIVATIVE;

ANTIBACTERIAL ACTIVITY; ARTICLE; BROTH DILUTION; CONTROLLED STUDY; DRUG DESIGN; DRUG EFFICACY; DRUG SYNTHESIS; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHARMACOPHORE; COMPARATIVE STUDY; DRUG EFFECTS; MYCOBACTERIUM; PHYSIOLOGY; SYNTHESIS;

MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS;

ANTI-BACTERIAL AGENTS; DRUG DESIGN; HYDRAZONES; MYCOBACTERIUM; QUINOLINES;

EID: 74349084588     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2009.12.045     Document Type: Article

References (24)

1. WHO Global Tuberculosis Control Report, 2008.
2. Jain R., Vaitilingam B., Nayyar A., and Palde P.B. Bioorg. Med. Chem. Lett. 13 (2003) 1051
3. WHO Weekly epidemiological record No. 15. 2003, 78, 121.
4. Zignol M., Hosseini M.S., Wright A., Weezenbeek C.L., Nunn P., Watt C.J., Williams C.G., and Dye C. J. Infect. Dis. 194 (2006) 479
5. Murugesan D., Palaniappan S., Perumal Y., Arnab C., Valakunja N., and Dharmarajan S. Bioorg. Med. Chem. 16 (2008) 3408
6. Annamaria L., Jialin M., Baojie W., Yuehong W., Scott G.F., and Alan P.K. J. Med. Chem. 52 (2009) 2109
7. Sarva J., Yasuyoshi I., Baojie W., Scott G.F., and Alan P.K. Chem. Med. Chem 1 (2006) 593
8. Amit N., Vikramdeep M., Alpeshkumar M., Evans C., and Rahul J. Bioorg. Med. Chem. 15 (2007) 626
9. Dinakaran M., Senthilkumar P., Yogeeswari P., China A., Nagaraja V., and Dharmarajan S. Int. J. Antimicrob. Agents 31 (2008) 337
10. Amit N., Alpeshkumar M., Evans C., and Rahul J. Bioorg. Med. Chem. 14 (2006) 7302
11. Tuberculosis, 2008, Vol. 88, pp 168-169.
12. Jialin M., Yuehong W., Baojie W., Alan P.K., and Scott G.F. Chem. Med. Chem. 2 (2007) 1624
13. Karl D., Xilin Z., and Barry K. Lancet Infect. Dis. 8 (2008) 273-275
14. Jonge de., Koymans L.H., Guillemont J.E., Koul A., and Andries K. Proteins 67 (2007) 971
15. Raju B., Kathleen M., Sampathkumar A., Hardwin ODowd., Hongwu G., Marcela G., Corinne H., Charlotte W., Wen W., Zhengyu Y., Richard W., Joaquim T., and Dinesh V.P. Bioorg. Med. Chem. Lett. 13 (2003) 2413
16. Imramovský A., Polanc S., Vinšová J., Kočevar M., Jampílek J., Rečková Z., and Kaustová J. Bioorg. Med. Chem. 15 (2007) 2551
17. Nayyar A., Malde A., Coutinho E., and Jain R. Bioorg. Med. Chem. 14 (2006) 7302
18. Sriram D., Yogeeswari P., and Devakaram R.V. Bioorg. Med. Chem. 14 (2006) 3113
19. Sinha N., Jain S., Tilekar A., Upadhayaya R.S., Kishore N., Jana G.H., and Arora S.K. Bioorg. Med. Chem. Lett. 15 (2005) 1573
20. Sumesh E., Adhikari A.V., and Shetty N.S. Eur. J. Med. Chem. 11 (2009) 4637
21. Steven, W. E.; Milan B.; Cheol-Min P. US Patent 0,272,744 A1, 2005.
22. Neetu K.T., and Jaya S.T. J. Antimicrob. Chemother. (2007) 1
23. M. tuberculosis strains were grown in Middlebrook 7H9 broth (Difco BBL, Sparks, MD, USA) supplemented with 10% OADC Becton Dickinson, Sparks, MD, USA). The culture was diluted to McFarland 2 standard with the same medium. From this, 50 μL of this culture was added to 150 μL of fresh medium in 96 well microtitre plates. Stock solutions (2 mg/mL) of the test compounds were prepared in dimethyl formamide (DMF). The compounds were tested at 1, 10 and 100 μg/mL concentrations. Further the second level testing was carried out at concentrations 0.3125, 0.625, 1.25, 2.5, and 5 μg/mL. Control tubes had the same volumes of DMF without any substrate. Rifampicin (RIF) and isoniazid (INH) was used as the reference compounds. After incubation at 37 °C for 7 days, 20 μL of 0.01% Resazurin (Sigma, St. Louis. MO, USA) in water was added to each tube. Resazurin, a redox dye, is blue in the oxidized state and turns pink when reduced by the growth of viable cells. The control tubes showed a colour change from blue to pink after 1 h at 37 °C. Compounds which prevented the change of colour of the dye were considered to be inhibitory to M. tuberculosis.
24. Gundersen L.L., Nissen-Meyer J., and Spilsberg B. J. Med. Chem. 45 (2002) 1383